DEAL Barcode Assay to Enable Precision Medicine
07/21/2016
Researchers at the Nanosystems Biology Cancer Center at CalTech focus on the development and validation of tools for early detection and stratification of cancer through rapid and quantitative measurement of panels of serum and tissue-based biomarkers. The image above shows the DEAL (DNA-encoded antibody library) barcode assay, a high density information test for human blood proteins designed to show the individual identities of every human disease, allowing for personalized medicine.
.png)
No hay comentarios:
Publicar un comentario